Sector: MedicalBPAX (NASDAQ: BPAX)
Headlines
- Lambert, Edwards & Associates Hosts 5th Annual SMID-West Stock Conference in Chicago on Dec. 10
Nov 17, 2009 09:35 AM | ACO, API, BPAX, DFZ, DLA, GLDD
- BioSante Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference
Nov 17, 2009 08:01 AM | BPAX
- BioSante Pharmaceuticals Comments on Boehringer Ingelheim Clinical Test Results in Treatment of Female Sexual Dysfunction
Nov 16, 2009 12:30 PM | BPAX
- BioSante Pharmaceuticals to Present at Merriman Curhan Ford's Investor Summit
Nov 10, 2009 08:01 AM | BPAX
- BioSante Pharmaceuticals to Present at the Oppenheimer Health Care Conference
Oct 29, 2009 08:00 AM | BPAX
- BioSante Pharmaceuticals to Present at the Bio Investor Forum
Oct 22, 2009 07:45 AM | BPAX
- BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
Oct 20, 2009 07:30 AM | BPAX
- BioSante Pharmaceuticals and Cell Genesys Announce Completion of Merger
Oct 14, 2009 01:17 PM | BPAX, CEGE
- Pre-Market: Health Care Shares Mixed in Pre-Market Session - BioSante Pharma Shareholders OK Cell Genesys Merger
Oct 01, 2009 09:20 AM | BPAX, CEGE, CTIC, HALO, RVSN, VICL
- BioSante (NASDAQ: BPAX): LibiGel Provides Big Upside Potential
Sep 27, 2009 02:40 PM | BPAX, CEGE, TEVA, VVUS
- BioSante Pharmaceuticals Reports Third Quarter 2009 Financial Results
Nov 09, 2009 04:55 PM | BPAX
- BioSante Pharmaceuticals and Cell Genesys Announce Approval of Merger By BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 14, 2009
Sep 30, 2009 04:53 PM | BPAX, CEGE
- BioSante Pharmaceuticals and Cell Genesys Announce Final Exchange Ratio for Merger
Sep 22, 2009 06:51 PM | BPAX, CEGE
- BioSante Pharmaceuticals Closes $12 Million Registered Direct Offering
Aug 14, 2009 04:52 PM | BPAX, RODM
- BioSante Pharmaceuticals to Raise $12 Million in Registered Direct Offering
Aug 13, 2009 02:52 PM | BPAX, RODM
- WallStreet Research Hosts Small Cap Conference V in New York City - www.SmallCapConference.org
Aug 10, 2009 06:05 AM | BPAX, ONSM, PBIO
- BioSante Pharmaceuticals Reports Second Quarter 2009 Financial Results
Aug 07, 2009 05:56 PM | BPAX, CEGE
- BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Jun 30, 2009 08:28 AM | BPAX, CEGE
- BioSante Pharmaceuticals Comments on Study Showing No Increased Risk of Breast Cancer in Women Using Testosterone for Low Libido
Jun 29, 2009 08:14 AM | BPAX
- Paper in Journal of Sexual Medicine Cites Need for FDA-Approved Testosterone Treatment to Replace Growing Off-Label Use
Jun 25, 2009 08:02 AM | BPAX
- Form 3 POTTS JOHN T JR For: Oct 14 (10K)
Oct 15, 2009 08:30 PM
- Form 3 SHERWIN STEPHEN A For: Oct 14 (10K)
Oct 15, 2009 08:26 PM
- Form 4 SIMES STEPHEN M For: Feb 02 (10K)
Feb 02, 2009 08:26 PM
- Form 4 DONENBERG PHILIP B For: Feb 02 (10K)
Feb 02, 2009 08:21 PM
- Form 4 BIOSANTE PHARMACEUTICALS For: Feb 02 Filed by: MANGANO ROSS J (10K)
Feb 02, 2009 08:19 PM
- Form 4 KJAER PETER For: Feb 02 (10K)
Feb 02, 2009 08:10 PM
- Form 4 ROSENOW EDWARD C III For: Feb 02 (10K)
Feb 02, 2009 08:06 PM
- Form 4 SULLIVAN LOUIS W For: Feb 02 (10K)
Feb 02, 2009 08:00 PM
- Form 4 HOLUBOW FRED For: Feb 02 (10K)
Feb 02, 2009 07:59 PM
- Form 4 SIMES STEPHEN M For: Jan 02 (10K)
Jan 05, 2009 10:26 AM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
BPAX
|
Compare to S&P
|
| YTD |
57.00 %
|
29.94 %
|
| 4 Weeks |
-13.26 %
|
-14.20 %
|
| 12 Weeks |
-15.14 %
|
-19.99 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 5.88 %
|
|
EPS Growth in Last Year: 33.33 %
|
|
Sales Growth in Last Quarter: 83.33 %
|
|
Sales Growth in Last Quarter: 450.00 %
|
|
